INBS — Intelligent Bio Solutions Inc.

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $1.76 Analyst target: $12.00 Upside: 581.82%

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (INBS) is a pioneering biotechnology company focused on delivering cutting-edge diagnostic solutions and biomarker-driven technologies, specifically designed for drug abuse testing and monitoring. Utilizing advanced scientific methodologies, INBS offers rapid and precise testing options that enhance clinical decision-making processes and improve patient outcomes. In a healthcare landscape increasingly reliant on innovative diagnostic tools, INBS is well-positioned to make substantial contributions to this evolving field, reinforcing its dedication to advancing healthcare quality and operational effectiveness.

See the full interactive analysis & chart →

Informational only — not investment advice.